Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
RUNX1
|
ENSG00000159216.19 | RUNX family transcription factor 1 |
RUNX2
|
ENSG00000124813.23 | RUNX family transcription factor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RUNX2 | hg38_v1_chr6_+_45422485_45422561 | 0.72 | 2.9e-06 | Click! |
RUNX1 | hg38_v1_chr21_-_34889735_34889790 | 0.59 | 4.2e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_89143133 | 16.47 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr17_-_31314040 | 14.10 |
ENST00000330927.5
|
EVI2B
|
ecotropic viral integration site 2B |
chr17_-_31314066 | 13.93 |
ENST00000577894.1
|
EVI2B
|
ecotropic viral integration site 2B |
chr11_+_60971777 | 13.70 |
ENST00000542157.5
ENST00000433107.6 ENST00000352009.9 ENST00000452451.6 |
CD6
|
CD6 molecule |
chr11_+_60971668 | 13.24 |
ENST00000313421.11
|
CD6
|
CD6 molecule |
chr1_+_209756032 | 12.29 |
ENST00000400959.7
ENST00000367025.8 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr4_-_83114715 | 11.32 |
ENST00000426923.2
ENST00000311507.9 ENST00000509973.5 |
PLAC8
|
placenta associated 8 |
chr16_+_85908988 | 11.06 |
ENST00000566369.1
|
IRF8
|
interferon regulatory factor 8 |
chr1_-_113871665 | 11.03 |
ENST00000528414.5
ENST00000460620.5 ENST00000359785.10 ENST00000420377.6 ENST00000525799.1 ENST00000538253.5 |
PTPN22
|
protein tyrosine phosphatase non-receptor type 22 |
chr4_+_70226116 | 10.85 |
ENST00000317987.6
|
FDCSP
|
follicular dendritic cell secreted protein |
chrX_-_71618455 | 10.77 |
ENST00000373691.4
ENST00000373693.4 |
CXCR3
|
C-X-C motif chemokine receptor 3 |
chr19_-_51372640 | 10.60 |
ENST00000600427.5
ENST00000221978.10 |
NKG7
|
natural killer cell granule protein 7 |
chr5_+_35856883 | 10.14 |
ENST00000506850.5
ENST00000303115.8 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
chr1_+_209756149 | 9.92 |
ENST00000367026.7
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr2_+_90038848 | 9.66 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr1_+_198638968 | 9.63 |
ENST00000348564.11
ENST00000530727.5 ENST00000442510.8 ENST00000645247.1 ENST00000367367.8 ENST00000367364.5 ENST00000413409.6 |
PTPRC
|
protein tyrosine phosphatase receptor type C |
chr14_-_24634160 | 9.59 |
ENST00000616551.1
ENST00000382542.5 ENST00000216341.9 ENST00000526004.1 ENST00000415355.7 |
GZMB
|
granzyme B |
chr1_+_159800503 | 9.53 |
ENST00000536257.5
ENST00000321935.10 |
FCRL6
|
Fc receptor like 6 |
chr2_-_157444044 | 9.33 |
ENST00000264192.8
|
CYTIP
|
cytohesin 1 interacting protein |
chr22_+_22818994 | 8.94 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 |
chr16_+_31355165 | 8.90 |
ENST00000562918.5
ENST00000268296.9 |
ITGAX
|
integrin subunit alpha X |
chr5_-_39219555 | 8.85 |
ENST00000512982.4
ENST00000351578.12 ENST00000509072.5 ENST00000504542.1 ENST00000506557.5 |
FYB1
|
FYN binding protein 1 |
chr8_-_133060347 | 8.84 |
ENST00000427060.6
|
SLA
|
Src like adaptor |
chr17_-_36196748 | 8.63 |
ENST00000619989.1
|
CCL3L1
|
C-C motif chemokine ligand 3 like 1 |
chr1_-_24964984 | 8.60 |
ENST00000338888.3
ENST00000399916.5 |
RUNX3
|
RUNX family transcription factor 3 |
chrX_-_49264668 | 8.53 |
ENST00000455775.7
ENST00000652559.1 ENST00000376207.10 ENST00000557224.6 ENST00000684155.1 ENST00000376199.7 |
FOXP3
|
forkhead box P3 |
chr7_+_142313144 | 8.49 |
ENST00000390357.3
|
TRBV4-1
|
T cell receptor beta variable 4-1 |
chr2_+_203706475 | 8.36 |
ENST00000374481.7
ENST00000458610.6 |
CD28
|
CD28 molecule |
chr16_+_29663219 | 8.30 |
ENST00000436527.5
ENST00000360121.4 ENST00000652691.1 ENST00000449759.2 |
SPN
QPRT
|
sialophorin quinolinate phosphoribosyltransferase |
chr14_+_21918161 | 8.24 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
chr20_+_46008900 | 8.13 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 |
chr16_-_3256587 | 8.13 |
ENST00000536379.5
ENST00000541159.5 ENST00000339854.8 ENST00000219596.6 |
MEFV
|
MEFV innate immuity regulator, pyrin |
chr19_+_54906140 | 8.09 |
ENST00000291890.9
ENST00000598576.5 ENST00000594765.5 ENST00000350790.9 ENST00000338835.9 ENST00000357397.5 |
NCR1
|
natural cytotoxicity triggering receptor 1 |
chr12_-_53200443 | 8.08 |
ENST00000550743.6
|
ITGB7
|
integrin subunit beta 7 |
chr1_+_209768597 | 7.92 |
ENST00000487271.5
ENST00000477431.1 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr7_+_142560423 | 7.89 |
ENST00000620569.1
|
TRBV12-3
|
T cell receptor beta variable 12-3 |
chr14_-_24609660 | 7.87 |
ENST00000557220.6
ENST00000216338.9 ENST00000382548.4 |
GZMH
|
granzyme H |
chr2_+_203706614 | 7.58 |
ENST00000324106.9
|
CD28
|
CD28 molecule |
chr1_+_198639162 | 7.55 |
ENST00000418674.1
|
PTPRC
|
protein tyrosine phosphatase receptor type C |
chr17_-_63932261 | 7.52 |
ENST00000349817.2
ENST00000006750.8 ENST00000392795.7 |
CD79B
|
CD79b molecule |
chr6_-_41201128 | 7.48 |
ENST00000483722.2
|
TREML2
|
triggering receptor expressed on myeloid cells like 2 |
chr14_+_22281097 | 7.47 |
ENST00000390465.2
|
TRAV38-2DV8
|
T cell receptor alpha variable 38-2/delta variable 8 |
chr5_-_39202991 | 7.31 |
ENST00000515010.5
|
FYB1
|
FYN binding protein 1 |
chr14_-_24634266 | 7.31 |
ENST00000382540.5
|
GZMB
|
granzyme B |
chr1_+_203765168 | 7.18 |
ENST00000367217.5
ENST00000442561.7 |
LAX1
|
lymphocyte transmembrane adaptor 1 |
chr20_-_1619996 | 7.15 |
ENST00000381603.7
ENST00000381605.9 ENST00000279477.11 ENST00000568365.1 ENST00000564763.1 |
SIRPB1
ENSG00000260861.6
|
signal regulatory protein beta 1 novel protein, SIRPB1-SIRPD readthrough |
chr1_+_17308194 | 7.14 |
ENST00000375453.5
ENST00000375448.4 |
PADI4
|
peptidyl arginine deiminase 4 |
chr1_-_153544997 | 7.12 |
ENST00000368715.5
|
S100A4
|
S100 calcium binding protein A4 |
chr7_+_142529268 | 7.05 |
ENST00000612787.1
|
TRBV7-9
|
T cell receptor beta variable 7-9 |
chrX_+_48683763 | 7.01 |
ENST00000376701.5
|
WAS
|
WASP actin nucleation promoting factor |
chr17_-_48185179 | 6.97 |
ENST00000579336.1
|
SKAP1
|
src kinase associated phosphoprotein 1 |
chr22_+_22030934 | 6.90 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr19_-_35742431 | 6.85 |
ENST00000592537.5
ENST00000246532.6 ENST00000588992.5 |
IGFLR1
|
IGF like family receptor 1 |
chr14_+_21712313 | 6.81 |
ENST00000390424.2
|
TRAV2
|
T cell receptor alpha variable 2 |
chr6_+_31575557 | 6.79 |
ENST00000449264.3
|
TNF
|
tumor necrosis factor |
chr1_+_172659095 | 6.78 |
ENST00000367721.3
ENST00000340030.4 |
FASLG
|
Fas ligand |
chr11_-_58578096 | 6.60 |
ENST00000528954.5
ENST00000528489.1 |
LPXN
|
leupaxin |
chr1_+_209756101 | 6.58 |
ENST00000479796.5
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr19_-_51372686 | 6.48 |
ENST00000595217.1
|
NKG7
|
natural killer cell granule protein 7 |
chr8_+_11494367 | 6.38 |
ENST00000259089.9
ENST00000529894.1 |
BLK
|
BLK proto-oncogene, Src family tyrosine kinase |
chr3_-_151203201 | 6.36 |
ENST00000480322.1
ENST00000309180.6 |
GPR171
|
G protein-coupled receptor 171 |
chr16_-_67999468 | 6.24 |
ENST00000393847.6
ENST00000573808.1 ENST00000572624.5 |
DPEP2
|
dipeptidase 2 |
chr22_+_22098683 | 6.22 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
chr1_+_209768482 | 6.21 |
ENST00000367023.5
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr16_+_23835946 | 6.19 |
ENST00000321728.12
ENST00000643927.1 |
PRKCB
|
protein kinase C beta |
chr22_+_22771791 | 6.18 |
ENST00000390313.3
|
IGLV3-12
|
immunoglobulin lambda variable 3-12 |
chr7_+_142563730 | 6.11 |
ENST00000617347.1
|
TRBV12-4
|
T cell receptor beta variable 12-4 |
chr2_-_89085787 | 6.02 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chrY_+_2841864 | 6.00 |
ENST00000430575.1
|
RPS4Y1
|
ribosomal protein S4 Y-linked 1 |
chr19_-_8502621 | 5.91 |
ENST00000600262.1
ENST00000423345.5 |
PRAM1
|
PML-RARA regulated adaptor molecule 1 |
chr19_-_54313074 | 5.89 |
ENST00000486742.2
ENST00000432233.8 |
LILRA5
|
leukocyte immunoglobulin like receptor A5 |
chr12_-_68159732 | 5.84 |
ENST00000229135.4
|
IFNG
|
interferon gamma |
chr19_-_51751854 | 5.81 |
ENST00000304748.5
ENST00000595042.5 |
FPR1
|
formyl peptide receptor 1 |
chr17_-_63699162 | 5.80 |
ENST00000582055.1
|
LIMD2
|
LIM domain containing 2 |
chr17_-_63699730 | 5.77 |
ENST00000578061.5
|
LIMD2
|
LIM domain containing 2 |
chr13_-_46182136 | 5.69 |
ENST00000323076.7
|
LCP1
|
lymphocyte cytosolic protein 1 |
chr16_+_30183595 | 5.68 |
ENST00000219150.10
ENST00000570045.5 ENST00000565497.5 ENST00000570244.5 |
CORO1A
|
coronin 1A |
chr3_+_32951636 | 5.64 |
ENST00000330953.6
|
CCR4
|
C-C motif chemokine receptor 4 |
chr4_-_38804783 | 5.63 |
ENST00000308979.7
ENST00000505940.1 ENST00000515861.5 |
TLR1
|
toll like receptor 1 |
chr12_-_108632073 | 5.61 |
ENST00000228463.6
|
SELPLG
|
selectin P ligand |
chr22_+_22720615 | 5.60 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr1_-_168543990 | 5.58 |
ENST00000367819.3
|
XCL2
|
X-C motif chemokine ligand 2 |
chr20_-_1588632 | 5.50 |
ENST00000262929.9
ENST00000567028.5 |
SIRPB1
ENSG00000260861.6
|
signal regulatory protein beta 1 novel protein, SIRPB1-SIRPD readthrough |
chr5_-_139389905 | 5.46 |
ENST00000302125.9
|
MZB1
|
marginal zone B and B1 cell specific protein |
chr5_-_150086511 | 5.40 |
ENST00000675795.1
|
CSF1R
|
colony stimulating factor 1 receptor |
chr3_+_113532508 | 5.39 |
ENST00000264852.9
|
SIDT1
|
SID1 transmembrane family member 1 |
chr9_-_127778659 | 5.37 |
ENST00000314830.13
|
SH2D3C
|
SH2 domain containing 3C |
chr17_-_74546082 | 5.35 |
ENST00000330793.2
|
CD300C
|
CD300c molecule |
chr6_-_127900958 | 5.32 |
ENST00000434358.3
ENST00000630369.2 ENST00000368248.4 |
THEMIS
|
thymocyte selection associated |
chr20_+_56412249 | 5.25 |
ENST00000679887.1
ENST00000434344.2 |
CASS4
|
Cas scaffold protein family member 4 |
chr2_+_85694350 | 5.17 |
ENST00000524600.5
ENST00000263863.9 |
GNLY
|
granulysin |
chr1_+_145719483 | 5.15 |
ENST00000369288.7
|
CD160
|
CD160 molecule |
chr17_+_4932248 | 5.13 |
ENST00000329125.6
|
GP1BA
|
glycoprotein Ib platelet subunit alpha |
chr11_+_35176696 | 5.09 |
ENST00000528455.5
|
CD44
|
CD44 molecule (Indian blood group) |
chr17_-_36090133 | 5.07 |
ENST00000613922.2
|
CCL3
|
C-C motif chemokine ligand 3 |
chr2_+_30232150 | 5.04 |
ENST00000401506.1
ENST00000407930.2 |
LBH
|
LBH regulator of WNT signaling pathway |
chr14_+_21868822 | 5.01 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
chr8_+_27311471 | 5.01 |
ENST00000397501.5
|
PTK2B
|
protein tyrosine kinase 2 beta |
chr7_+_142300924 | 4.96 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
chr5_+_157180816 | 4.96 |
ENST00000422843.8
|
ITK
|
IL2 inducible T cell kinase |
chr17_-_75843708 | 4.93 |
ENST00000590762.5
|
UNC13D
|
unc-13 homolog D |
chr2_+_90114838 | 4.91 |
ENST00000417279.3
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 |
chr16_+_27427242 | 4.89 |
ENST00000395754.4
|
IL21R
|
interleukin 21 receptor |
chrX_-_71111448 | 4.89 |
ENST00000456850.6
ENST00000473378.1 ENST00000374202.7 ENST00000374188.7 |
IL2RG
|
interleukin 2 receptor subunit gamma |
chr12_-_9607903 | 4.86 |
ENST00000229402.4
|
KLRB1
|
killer cell lectin like receptor B1 |
chr14_-_105845677 | 4.85 |
ENST00000390556.6
|
IGHD
|
immunoglobulin heavy constant delta |
chr8_-_21913671 | 4.82 |
ENST00000523932.1
ENST00000276420.9 |
DOK2
|
docking protein 2 |
chr19_-_54280498 | 4.82 |
ENST00000391746.5
|
LILRB2
|
leukocyte immunoglobulin like receptor B2 |
chr2_+_85694399 | 4.79 |
ENST00000409696.7
|
GNLY
|
granulysin |
chr2_+_68365274 | 4.78 |
ENST00000234313.8
|
PLEK
|
pleckstrin |
chr1_-_92486049 | 4.76 |
ENST00000427103.5
|
GFI1
|
growth factor independent 1 transcriptional repressor |
chr11_+_35176611 | 4.75 |
ENST00000279452.10
|
CD44
|
CD44 molecule (Indian blood group) |
chr11_+_35176575 | 4.74 |
ENST00000526000.6
|
CD44
|
CD44 molecule (Indian blood group) |
chr11_+_35176639 | 4.72 |
ENST00000527889.6
|
CD44
|
CD44 molecule (Indian blood group) |
chr1_+_206470463 | 4.71 |
ENST00000581977.7
ENST00000578328.6 ENST00000584998.5 ENST00000579827.6 |
IKBKE
|
inhibitor of nuclear factor kappa B kinase subunit epsilon |
chrX_+_136648138 | 4.69 |
ENST00000370629.7
|
CD40LG
|
CD40 ligand |
chr17_+_4932285 | 4.59 |
ENST00000611961.1
|
GP1BA
|
glycoprotein Ib platelet subunit alpha |
chr11_+_65879791 | 4.58 |
ENST00000528419.6
ENST00000307886.8 ENST00000526034.2 ENST00000679584.1 ENST00000680443.1 ENST00000680670.1 |
CTSW
|
cathepsin W |
chr6_+_45328203 | 4.58 |
ENST00000371432.7
ENST00000647337.2 ENST00000371438.5 |
RUNX2
|
RUNX family transcription factor 2 |
chr22_+_22880706 | 4.56 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr7_+_142587857 | 4.51 |
ENST00000617639.1
|
TRBV14
|
T cell receptor beta variable 14 |
chr17_+_7336502 | 4.50 |
ENST00000158762.8
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr3_-_112499457 | 4.49 |
ENST00000334529.10
|
BTLA
|
B and T lymphocyte associated |
chr7_+_142615710 | 4.48 |
ENST00000611520.1
|
TRBV18
|
T cell receptor beta variable 18 |
chr1_+_116754422 | 4.43 |
ENST00000369478.4
ENST00000369477.1 |
CD2
|
CD2 molecule |
chr14_-_106117159 | 4.43 |
ENST00000390601.3
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 |
chr1_-_206921867 | 4.39 |
ENST00000628511.2
ENST00000367091.8 |
FCMR
|
Fc fragment of IgM receptor |
chr19_+_1067493 | 4.39 |
ENST00000586866.5
|
ARHGAP45
|
Rho GTPase activating protein 45 |
chr9_-_134917872 | 4.36 |
ENST00000616356.4
ENST00000371806.4 |
FCN1
|
ficolin 1 |
chr17_+_7336557 | 4.29 |
ENST00000570457.6
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr4_-_152679984 | 4.27 |
ENST00000304385.8
ENST00000504064.1 |
TMEM154
|
transmembrane protein 154 |
chr19_-_14674829 | 4.26 |
ENST00000443157.6
ENST00000253673.6 |
ADGRE3
|
adhesion G protein-coupled receptor E3 |
chr11_-_128587551 | 4.23 |
ENST00000392668.8
|
ETS1
|
ETS proto-oncogene 1, transcription factor |
chrX_+_136648214 | 4.21 |
ENST00000370628.2
|
CD40LG
|
CD40 ligand |
chr1_-_206921987 | 4.18 |
ENST00000530505.1
ENST00000442471.4 |
FCMR
|
Fc fragment of IgM receptor |
chr3_+_143119749 | 4.16 |
ENST00000309575.5
|
CHST2
|
carbohydrate sulfotransferase 2 |
chr19_+_1067144 | 4.15 |
ENST00000313093.7
|
ARHGAP45
|
Rho GTPase activating protein 45 |
chr19_+_51127030 | 4.11 |
ENST00000599948.1
|
SIGLEC9
|
sialic acid binding Ig like lectin 9 |
chr19_-_43780957 | 4.07 |
ENST00000648319.1
|
KCNN4
|
potassium calcium-activated channel subfamily N member 4 |
chr12_+_47216531 | 4.04 |
ENST00000548348.1
ENST00000549500.1 |
PCED1B
|
PC-esterase domain containing 1B |
chr11_+_64340191 | 4.01 |
ENST00000356786.10
|
CCDC88B
|
coiled-coil domain containing 88B |
chr11_+_72135718 | 4.01 |
ENST00000611028.3
ENST00000546166.1 ENST00000442948.3 |
FOLR3
|
folate receptor gamma |
chr17_-_7114240 | 4.00 |
ENST00000446679.6
|
ASGR2
|
asialoglycoprotein receptor 2 |
chr22_+_24427587 | 3.98 |
ENST00000337539.12
|
ADORA2A
|
adenosine A2a receptor |
chr12_+_128853462 | 3.96 |
ENST00000281703.11
ENST00000442111.6 |
GLT1D1
|
glycosyltransferase 1 domain containing 1 |
chr19_-_42132465 | 3.95 |
ENST00000529067.5
ENST00000529952.5 ENST00000342301.8 ENST00000389341.9 |
POU2F2
|
POU class 2 homeobox 2 |
chr7_+_142424942 | 3.94 |
ENST00000426318.2
|
TRBV10-2
|
T cell receptor beta variable 10-2 |
chr3_+_186974957 | 3.94 |
ENST00000438590.5
|
ST6GAL1
|
ST6 beta-galactoside alpha-2,6-sialyltransferase 1 |
chr6_+_31586680 | 3.93 |
ENST00000339530.8
|
LST1
|
leukocyte specific transcript 1 |
chr5_+_134115563 | 3.91 |
ENST00000517851.5
ENST00000521639.5 ENST00000522375.5 ENST00000378560.8 ENST00000520958.5 ENST00000518915.5 ENST00000395023.5 |
TCF7
|
transcription factor 7 |
chr19_-_50365625 | 3.90 |
ENST00000598915.5
ENST00000253719.7 |
NAPSA
|
napsin A aspartic peptidase |
chr8_+_22578249 | 3.87 |
ENST00000456545.5
|
PDLIM2
|
PDZ and LIM domain 2 |
chr4_-_108166750 | 3.86 |
ENST00000515500.5
|
LEF1
|
lymphoid enhancer binding factor 1 |
chr14_+_22105305 | 3.84 |
ENST00000390453.1
|
TRAV24
|
T cell receptor alpha variable 24 |
chr1_-_153375591 | 3.84 |
ENST00000368737.5
|
S100A12
|
S100 calcium binding protein A12 |
chr19_-_14674886 | 3.84 |
ENST00000344373.8
ENST00000595472.1 |
ADGRE3
|
adhesion G protein-coupled receptor E3 |
chr17_-_63701140 | 3.80 |
ENST00000584645.1
|
LIMD2
|
LIM domain containing 2 |
chr2_+_87338511 | 3.80 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
chr4_-_70666492 | 3.78 |
ENST00000254801.9
ENST00000391614.7 |
JCHAIN
|
joining chain of multimeric IgA and IgM |
chr17_-_7114813 | 3.76 |
ENST00000254850.11
|
ASGR2
|
asialoglycoprotein receptor 2 |
chr22_-_42432369 | 3.76 |
ENST00000329021.10
|
NFAM1
|
NFAT activating protein with ITAM motif 1 |
chr4_-_70666884 | 3.75 |
ENST00000510614.5
|
JCHAIN
|
joining chain of multimeric IgA and IgM |
chr1_+_110873135 | 3.75 |
ENST00000271324.6
|
CD53
|
CD53 molecule |
chrX_+_37780049 | 3.74 |
ENST00000378588.5
|
CYBB
|
cytochrome b-245 beta chain |
chr14_-_106557465 | 3.73 |
ENST00000390625.3
|
IGHV3-49
|
immunoglobulin heavy variable 3-49 |
chr19_-_53824288 | 3.72 |
ENST00000324134.11
ENST00000391773.6 ENST00000391775.7 ENST00000345770.9 ENST00000391772.1 |
NLRP12
|
NLR family pyrin domain containing 12 |
chr7_+_142455120 | 3.71 |
ENST00000390369.2
|
TRBV7-4
|
T cell receptor beta variable 7-4 |
chr12_+_6946468 | 3.70 |
ENST00000543115.5
ENST00000399448.5 |
PTPN6
|
protein tyrosine phosphatase non-receptor type 6 |
chr14_-_91253925 | 3.70 |
ENST00000531499.2
|
GPR68
|
G protein-coupled receptor 68 |
chr17_-_1628341 | 3.68 |
ENST00000571650.5
|
SLC43A2
|
solute carrier family 43 member 2 |
chr16_+_81739027 | 3.66 |
ENST00000566191.5
ENST00000565272.5 ENST00000563954.5 ENST00000565054.5 |
ENSG00000261218.5
PLCG2
|
novel transcript phospholipase C gamma 2 |
chr4_-_108166715 | 3.66 |
ENST00000510624.5
|
LEF1
|
lymphoid enhancer binding factor 1 |
chr15_-_40307825 | 3.65 |
ENST00000456256.6
ENST00000557821.5 |
PLCB2
|
phospholipase C beta 2 |
chr17_+_44349050 | 3.65 |
ENST00000639447.1
|
GRN
|
granulin precursor |
chr19_-_42132391 | 3.64 |
ENST00000528894.8
ENST00000560804.6 ENST00000560558.5 ENST00000560398.5 ENST00000526816.6 ENST00000625670.2 |
POU2F2
|
POU class 2 homeobox 2 |
chr5_-_150113344 | 3.64 |
ENST00000286301.7
ENST00000511344.1 |
CSF1R
|
colony stimulating factor 1 receptor |
chr14_-_106301848 | 3.62 |
ENST00000390611.2
|
IGHV2-26
|
immunoglobulin heavy variable 2-26 |
chr17_+_77451244 | 3.61 |
ENST00000591088.5
|
SEPTIN9
|
septin 9 |
chr19_-_51646800 | 3.60 |
ENST00000599649.5
ENST00000429354.3 ENST00000360844.6 |
SIGLEC5
SIGLEC14
|
sialic acid binding Ig like lectin 5 sialic acid binding Ig like lectin 14 |
chr4_-_108166289 | 3.60 |
ENST00000512172.1
|
LEF1
|
lymphoid enhancer binding factor 1 |
chr1_-_206923183 | 3.59 |
ENST00000525793.5
|
FCMR
|
Fc fragment of IgM receptor |
chr3_-_13042419 | 3.59 |
ENST00000647458.1
|
IQSEC1
|
IQ motif and Sec7 domain ArfGEF 1 |
chr20_-_63568074 | 3.57 |
ENST00000427522.6
|
HELZ2
|
helicase with zinc finger 2 |
chr15_+_85555439 | 3.57 |
ENST00000558811.2
|
AKAP13
|
A-kinase anchoring protein 13 |
chr1_+_52633147 | 3.57 |
ENST00000517870.2
|
SHISAL2A
|
shisa like 2A |
chr12_-_10390023 | 3.57 |
ENST00000240618.11
|
KLRK1
|
killer cell lectin like receptor K1 |
chr11_-_58575846 | 3.54 |
ENST00000395074.7
|
LPXN
|
leupaxin |
chr11_+_1868673 | 3.54 |
ENST00000405957.6
|
LSP1
|
lymphocyte specific protein 1 |
chr2_-_157439403 | 3.53 |
ENST00000418920.5
|
CYTIP
|
cytohesin 1 interacting protein |
chr1_-_206923242 | 3.52 |
ENST00000529560.1
|
FCMR
|
Fc fragment of IgM receptor |
chr4_-_70666961 | 3.51 |
ENST00000510437.5
|
JCHAIN
|
joining chain of multimeric IgA and IgM |
chr15_+_74788542 | 3.51 |
ENST00000567571.5
|
CSK
|
C-terminal Src kinase |
chr5_-_95081858 | 3.50 |
ENST00000505465.1
|
MCTP1
|
multiple C2 and transmembrane domain containing 1 |
chr1_+_160739286 | 3.49 |
ENST00000359331.8
ENST00000495334.1 |
SLAMF7
|
SLAM family member 7 |
chr11_+_121576760 | 3.49 |
ENST00000532694.5
ENST00000534286.5 |
SORL1
|
sortilin related receptor 1 |
chr19_+_1067272 | 3.48 |
ENST00000590214.5
|
ARHGAP45
|
Rho GTPase activating protein 45 |
chr20_-_1657762 | 3.45 |
ENST00000303415.7
ENST00000381583.6 |
SIRPG
|
signal regulatory protein gamma |
chr10_-_46023445 | 3.45 |
ENST00000585132.5
|
NCOA4
|
nuclear receptor coactivator 4 |
chr19_-_14776756 | 3.44 |
ENST00000596991.6
ENST00000594294.5 ENST00000594076.5 ENST00000595839.5 ENST00000392965.7 ENST00000601345.5 |
ADGRE2
|
adhesion G protein-coupled receptor E2 |
chr19_-_54242751 | 3.43 |
ENST00000245621.6
ENST00000396365.6 |
LILRA6
|
leukocyte immunoglobulin like receptor A6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.6 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
3.8 | 22.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
3.6 | 10.7 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
3.5 | 10.4 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
3.3 | 10.0 | GO:0002818 | intracellular defense response(GO:0002818) |
2.9 | 8.7 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
2.7 | 8.2 | GO:0002432 | granuloma formation(GO:0002432) |
2.7 | 13.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
2.5 | 7.6 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
2.4 | 7.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
2.2 | 11.0 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
2.1 | 19.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
2.0 | 31.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
1.9 | 11.5 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
1.9 | 7.6 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
1.8 | 16.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.8 | 3.7 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
1.8 | 7.0 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
1.7 | 8.6 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
1.6 | 11.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.6 | 3.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
1.6 | 4.8 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
1.5 | 13.8 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.5 | 4.4 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
1.4 | 2.9 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
1.4 | 19.3 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
1.4 | 6.9 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.4 | 6.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.3 | 3.8 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.3 | 5.0 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
1.2 | 3.7 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
1.2 | 4.8 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
1.2 | 9.6 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
1.2 | 3.5 | GO:1902771 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
1.1 | 5.7 | GO:0032796 | uropod organization(GO:0032796) |
1.1 | 1.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
1.1 | 6.3 | GO:1903904 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
1.0 | 8.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
1.0 | 12.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.0 | 3.0 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
1.0 | 3.0 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
1.0 | 11.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
1.0 | 7.9 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
1.0 | 2.9 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.9 | 3.7 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.9 | 2.8 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.9 | 3.6 | GO:0060061 | Spemann organizer formation(GO:0060061) positive regulation of dermatome development(GO:0061184) |
0.9 | 6.1 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.8 | 4.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.8 | 2.5 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
0.8 | 2.5 | GO:2001025 | response to cyclosporin A(GO:1905237) positive regulation of response to drug(GO:2001025) |
0.8 | 8.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.8 | 2.4 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.8 | 11.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.8 | 4.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.8 | 5.6 | GO:0070269 | pyroptosis(GO:0070269) |
0.8 | 2.4 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.8 | 7.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.8 | 2.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.8 | 3.0 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.7 | 2.2 | GO:0035698 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.7 | 2.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.7 | 3.6 | GO:0052053 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.7 | 3.5 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.7 | 7.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.7 | 11.6 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.7 | 6.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.7 | 7.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.7 | 6.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.6 | 1.9 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
0.6 | 1.9 | GO:0035744 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) T-helper 1 cell cytokine production(GO:0035744) |
0.6 | 1.3 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.6 | 13.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.6 | 4.9 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.6 | 3.7 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.6 | 1.8 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.6 | 4.2 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.6 | 1.2 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.6 | 60.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.6 | 16.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.6 | 1.7 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.6 | 5.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.5 | 2.7 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.5 | 1.6 | GO:0030221 | basophil differentiation(GO:0030221) |
0.5 | 7.8 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.5 | 12.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.5 | 4.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 7.2 | GO:0002860 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.5 | 3.6 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.5 | 1.5 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
0.5 | 2.0 | GO:0044115 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.5 | 2.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.5 | 3.9 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.5 | 1.4 | GO:1903123 | regulation of thioredoxin peroxidase activity(GO:1903123) negative regulation of thioredoxin peroxidase activity(GO:1903124) negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation(GO:1903125) Wnt signalosome assembly(GO:1904887) negative regulation of peroxidase activity(GO:2000469) |
0.5 | 1.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.5 | 2.4 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.5 | 8.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.5 | 88.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.5 | 4.7 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.5 | 1.4 | GO:1904596 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.5 | 1.4 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.5 | 1.4 | GO:1990751 | positive regulation of Schwann cell migration(GO:1900149) positive regulation of glial cell migration(GO:1903977) regulation of Schwann cell chemotaxis(GO:1904266) positive regulation of Schwann cell chemotaxis(GO:1904268) Schwann cell chemotaxis(GO:1990751) |
0.5 | 14.0 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.5 | 1.4 | GO:0098583 | mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
0.4 | 1.8 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.4 | 2.2 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.4 | 7.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.4 | 14.8 | GO:0003094 | glomerular filtration(GO:0003094) |
0.4 | 11.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.4 | 1.3 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
0.4 | 1.7 | GO:0050705 | negative regulation of interleukin-1 alpha production(GO:0032690) regulation of interleukin-1 alpha secretion(GO:0050705) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.4 | 1.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.4 | 2.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.4 | 4.5 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.4 | 10.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 2.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.4 | 1.2 | GO:1904227 | regulation of UDP-glucose catabolic process(GO:0010904) negative regulation of UDP-glucose catabolic process(GO:0010905) regulation of glycogen synthase activity, transferring glucose-1-phosphate(GO:1904226) negative regulation of glycogen synthase activity, transferring glucose-1-phosphate(GO:1904227) |
0.4 | 3.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.4 | 1.2 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
0.4 | 1.6 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.4 | 1.6 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.4 | 1.1 | GO:1903004 | flavin adenine dinucleotide metabolic process(GO:0072387) regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
0.4 | 1.9 | GO:0072011 | glomerular endothelium development(GO:0072011) |
0.4 | 1.5 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.4 | 4.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 1.4 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.4 | 1.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.4 | 2.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 1.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.4 | 2.1 | GO:0006154 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
0.4 | 2.1 | GO:1902164 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) platelet alpha granule organization(GO:0070889) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.3 | 3.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 0.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.3 | 1.4 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.3 | 1.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.3 | 1.7 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.3 | 2.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 2.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.3 | 2.5 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) common myeloid progenitor cell proliferation(GO:0035726) |
0.3 | 2.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.3 | 1.2 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.3 | 0.9 | GO:0098503 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) DNA 3' dephosphorylation(GO:0098503) DNA 3' dephosphorylation involved in DNA repair(GO:0098504) polynucleotide 3' dephosphorylation(GO:0098506) |
0.3 | 5.6 | GO:0072678 | T cell migration(GO:0072678) |
0.3 | 0.9 | GO:0036292 | DNA rewinding(GO:0036292) |
0.3 | 4.6 | GO:0002507 | tolerance induction(GO:0002507) |
0.3 | 1.4 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.3 | 1.1 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.3 | 2.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.3 | 24.7 | GO:0031295 | T cell costimulation(GO:0031295) |
0.3 | 1.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.3 | 22.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.3 | 0.5 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.3 | 1.9 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.3 | 1.9 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.3 | 1.1 | GO:0035711 | T-helper 1 cell activation(GO:0035711) |
0.3 | 2.4 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.3 | 3.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.3 | 1.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.3 | 3.8 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.3 | 1.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 1.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.3 | 7.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 1.0 | GO:1905071 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
0.3 | 0.5 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 1.6 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.3 | 1.6 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.3 | 1.0 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.3 | 6.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.3 | 1.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 1.3 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.3 | 0.8 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.3 | 0.8 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.3 | 6.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 3.2 | GO:1903944 | negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.2 | 2.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 53.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 1.4 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
0.2 | 1.2 | GO:0039526 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
0.2 | 1.9 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.2 | 1.4 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 1.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 3.0 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 5.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 1.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 1.4 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.2 | 3.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.2 | 0.9 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
0.2 | 2.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.2 | 1.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 | 3.9 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.2 | 8.6 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 2.8 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 6.4 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 0.4 | GO:0097536 | thymus epithelium morphogenesis(GO:0097536) regulation of positive thymic T cell selection(GO:1902232) |
0.2 | 1.7 | GO:0061143 | nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) |
0.2 | 2.9 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 1.5 | GO:0043144 | snoRNA processing(GO:0043144) |
0.2 | 8.5 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 4.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.6 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.2 | 0.8 | GO:0032903 | viral protein processing(GO:0019082) negative regulation of neurotrophin production(GO:0032900) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.2 | 2.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.6 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
0.2 | 1.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 0.8 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.2 | 2.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.2 | 0.4 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.2 | 1.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 2.8 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 1.0 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.2 | 0.8 | GO:0071348 | response to interleukin-11(GO:0071105) cellular response to interleukin-11(GO:0071348) |
0.2 | 0.8 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) regulation of modification of synaptic structure(GO:1905244) |
0.2 | 0.6 | GO:1990637 | response to prolactin(GO:1990637) |
0.2 | 0.8 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.2 | 1.0 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.2 | 1.3 | GO:0007172 | signal complex assembly(GO:0007172) |
0.2 | 10.0 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.2 | 0.9 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.2 | 0.9 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.2 | 1.9 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.2 | 0.2 | GO:0032827 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.2 | 7.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 0.5 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.2 | 13.7 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.2 | 13.0 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 0.3 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
0.2 | 1.9 | GO:0032264 | IMP salvage(GO:0032264) |
0.2 | 3.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 1.9 | GO:0061087 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 2.7 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.2 | 1.2 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.2 | 2.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.5 | GO:0099403 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
0.2 | 1.2 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.2 | 1.7 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.2 | 0.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 1.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 0.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.5 | GO:0019046 | release from viral latency(GO:0019046) |
0.2 | 2.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 1.1 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.5 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.2 | 0.5 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.2 | 2.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 2.6 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.2 | 2.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 0.6 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 0.6 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.6 | GO:1903519 | bile acid signaling pathway(GO:0038183) apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 3.0 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 3.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.7 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.1 | 1.0 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.4 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
0.1 | 0.6 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.1 | 0.8 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 3.3 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 1.4 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.1 | 1.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.8 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.5 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.1 | 2.8 | GO:0072574 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
0.1 | 0.5 | GO:2000653 | histone H3-K79 methylation(GO:0034729) regulation of genetic imprinting(GO:2000653) |
0.1 | 1.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 2.6 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.1 | 0.4 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.1 | 1.0 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.1 | 1.8 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 2.8 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.4 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 5.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.5 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 6.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 1.6 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 1.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 1.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.5 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.4 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 0.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.5 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.1 | 87.5 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 2.1 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.1 | 0.5 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.1 | 3.6 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.5 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.1 | 0.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 1.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.6 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.8 | GO:0046618 | drug export(GO:0046618) |
0.1 | 1.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 1.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 3.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.4 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.1 | 8.0 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 2.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 1.0 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 1.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.7 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.1 | 1.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.6 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 16.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 1.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 1.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.4 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.3 | GO:0021593 | rhombomere morphogenesis(GO:0021593) rhombomere 3 morphogenesis(GO:0021658) |
0.1 | 0.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 1.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 0.9 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.7 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.1 | 0.5 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.9 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 1.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.7 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.8 | GO:0032887 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.1 | 0.4 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 3.1 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.1 | 0.4 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.1 | 0.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.4 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.1 | 0.7 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 1.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 4.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.4 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
0.1 | 2.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.4 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.2 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 1.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 1.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 6.4 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.2 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.1 | 0.8 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.2 | GO:0000393 | generation of catalytic spliceosome for second transesterification step(GO:0000350) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 1.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 2.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 2.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.3 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.1 | 0.5 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.3 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.3 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 1.4 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.1 | 0.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.7 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 2.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:1903824 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.1 | 1.3 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 0.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 1.1 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.1 | 1.2 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.1 | 0.3 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 1.4 | GO:0001502 | cartilage condensation(GO:0001502) |
0.1 | 0.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.1 | 0.6 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 2.9 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 1.4 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 0.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 3.5 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.1 | 0.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.9 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.1 | 0.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 1.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 2.9 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.9 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.8 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 1.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.3 | GO:0021604 | cranial nerve structural organization(GO:0021604) optic nerve morphogenesis(GO:0021631) optic nerve structural organization(GO:0021633) |
0.1 | 0.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 3.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.5 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.1 | 0.3 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.1 | 0.8 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.3 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.0 | 3.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.3 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.0 | 0.7 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 3.4 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.0 | 0.6 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.0 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 1.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 1.9 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 2.4 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.0 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 5.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.9 | GO:0006554 | lysine catabolic process(GO:0006554) |
0.0 | 0.2 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.0 | 0.3 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.0 | 0.7 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.5 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.0 | 0.3 | GO:0090656 | t-circle formation(GO:0090656) |
0.0 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 1.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.6 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 4.7 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.0 | 0.4 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.0 | 1.9 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.0 | 0.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 1.9 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 1.4 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.0 | 0.1 | GO:0070377 | negative regulation of ERK5 cascade(GO:0070377) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.3 | GO:0048313 | Golgi inheritance(GO:0048313) Golgi reassembly(GO:0090168) |
0.0 | 0.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 1.7 | GO:0071621 | granulocyte chemotaxis(GO:0071621) |
0.0 | 0.1 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.0 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 1.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.0 | 2.0 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.2 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.0 | 0.9 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 1.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.7 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.1 | GO:0009838 | abscission(GO:0009838) mitotic cytokinesis checkpoint(GO:0044878) |
0.0 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.3 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 1.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.5 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.0 | 0.8 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.7 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.1 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.0 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.7 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.0 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 1.3 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 1.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.5 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.2 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
0.0 | 2.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 1.4 | GO:0002223 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.0 | 0.6 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.6 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.4 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.1 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.0 | 0.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
0.0 | 0.0 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.0 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.2 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.0 | 0.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 1.4 | GO:0048208 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 1.4 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.0 | 0.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.9 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.3 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.0 | 0.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:0042262 | DNA protection(GO:0042262) |
0.0 | 0.4 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) protein K27-linked ubiquitination(GO:0044314) |
0.0 | 1.6 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.3 | GO:0050942 | regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.1 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) positive regulation of opsonization(GO:1903028) |
0.0 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.7 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.2 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.0 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.0 | 0.1 | GO:0044211 | CTP salvage(GO:0044211) |
0.0 | 1.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 12.4 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 1.1 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.3 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.3 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 27.5 | GO:0071753 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
2.7 | 13.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
2.2 | 8.7 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
1.6 | 19.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
1.5 | 9.2 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
1.5 | 7.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.5 | 11.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
1.2 | 38.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.2 | 3.5 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
1.1 | 6.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.9 | 24.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.8 | 2.5 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.8 | 2.4 | GO:0090651 | apical cytoplasm(GO:0090651) |
0.7 | 5.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.7 | 3.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.7 | 26.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 38.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.6 | 2.4 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.6 | 5.4 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.6 | 2.3 | GO:0036398 | TCR signalosome(GO:0036398) |
0.5 | 11.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.5 | 10.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 7.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 2.0 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.5 | 9.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.5 | 1.4 | GO:0032473 | cytoplasmic side of mitochondrial outer membrane(GO:0032473) caveola neck(GO:0099400) |
0.5 | 4.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 3.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.4 | 11.0 | GO:0097342 | ripoptosome(GO:0097342) |
0.4 | 5.0 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.4 | 1.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.4 | 22.4 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.4 | 7.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 3.1 | GO:1990037 | Lewy body core(GO:1990037) |
0.4 | 46.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.4 | 3.2 | GO:0044754 | autolysosome(GO:0044754) |
0.3 | 18.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 1.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.3 | 2.3 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 1.1 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.3 | 3.6 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 5.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 40.1 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.3 | 6.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 6.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 20.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.2 | 82.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 1.6 | GO:1990031 | pinceau fiber(GO:1990031) |
0.2 | 3.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 1.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.2 | 11.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 1.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 1.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.2 | 0.8 | GO:1990879 | CST complex(GO:1990879) |
0.2 | 8.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 1.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 3.6 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.2 | 3.0 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 1.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.9 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 10.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.6 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.1 | 1.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 1.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 1.7 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 10.9 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 1.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.7 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
0.1 | 9.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 6.1 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.3 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.1 | 0.6 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
0.1 | 11.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.4 | GO:0035101 | FACT complex(GO:0035101) |
0.1 | 0.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 29.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 2.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 2.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.4 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.1 | 0.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 3.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 1.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 2.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 2.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 1.3 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.8 | GO:0055028 | cortical microtubule(GO:0055028) |
0.1 | 0.7 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 5.2 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 29.8 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.2 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.1 | 2.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 1.8 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 2.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.3 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 2.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 1.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 6.4 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.2 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 8.4 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 1.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.3 | GO:0043291 | RAVE complex(GO:0043291) |
0.1 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.0 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.2 | GO:0071920 | cleavage body(GO:0071920) |
0.0 | 0.9 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 1.3 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 0.1 | GO:0032116 | SMC loading complex(GO:0032116) |
0.0 | 0.4 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.0 | 0.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.2 | GO:0097545 | axonemal outer doublet(GO:0097545) |
0.0 | 5.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 3.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.2 | GO:0036501 | UFD1-NPL4 complex(GO:0036501) |
0.0 | 1.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 6.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 6.2 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0090661 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.0 | 1.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.5 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.9 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.0 | 0.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 5.1 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 3.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.0 | 0.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 3.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 9.5 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 1.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 2.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 1.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 5.3 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 1.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 1.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 1.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 106.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.7 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.3 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.2 | GO:0034518 | RNA cap binding complex(GO:0034518) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 15.0 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
3.0 | 26.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
3.0 | 8.9 | GO:0005174 | CD40 receptor binding(GO:0005174) |
2.8 | 11.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
2.6 | 10.3 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
2.2 | 15.4 | GO:0019862 | IgA binding(GO:0019862) |
2.2 | 8.7 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.6 | 8.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.4 | 6.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.3 | 5.4 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
1.3 | 14.1 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
1.3 | 8.9 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
1.2 | 3.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
1.2 | 3.5 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
1.2 | 5.8 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
1.1 | 4.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.0 | 8.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.0 | 3.0 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
1.0 | 4.0 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
1.0 | 5.0 | GO:0048030 | disaccharide binding(GO:0048030) |
1.0 | 3.0 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
1.0 | 7.8 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
1.0 | 8.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.9 | 8.2 | GO:0030883 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.9 | 2.7 | GO:0031753 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
0.9 | 4.5 | GO:0004803 | transposase activity(GO:0004803) |
0.8 | 2.5 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.8 | 4.9 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.8 | 3.2 | GO:0045569 | TRAIL binding(GO:0045569) |
0.8 | 5.5 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.7 | 2.2 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.7 | 5.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.7 | 11.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.7 | 11.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.7 | 11.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.7 | 3.4 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.6 | 1.9 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
0.6 | 5.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.6 | 6.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.6 | 3.0 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.6 | 8.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.6 | 5.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.6 | 4.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.6 | 26.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.5 | 134.5 | GO:0003823 | antigen binding(GO:0003823) |
0.5 | 2.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.5 | 5.9 | GO:0019864 | IgG binding(GO:0019864) |
0.5 | 1.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.5 | 1.4 | GO:0036479 | GTP-dependent protein kinase activity(GO:0034211) peroxidase inhibitor activity(GO:0036479) |
0.5 | 9.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.5 | 7.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 6.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.5 | 4.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.5 | 1.4 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.4 | 3.1 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.4 | 2.2 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.4 | 4.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 2.0 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.4 | 2.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 8.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 2.4 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.4 | 1.2 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
0.4 | 1.6 | GO:0047977 | linoleate 13S-lipoxygenase activity(GO:0016165) hepoxilin-epoxide hydrolase activity(GO:0047977) |
0.4 | 3.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 18.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 2.3 | GO:0004875 | complement receptor activity(GO:0004875) |
0.4 | 16.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.4 | 2.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.4 | 3.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 1.9 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.4 | 8.7 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 7.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 1.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.4 | 2.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.4 | 2.5 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.3 | 1.7 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.3 | 7.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 1.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 13.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.3 | 0.9 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
0.3 | 0.9 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.3 | 1.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 2.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 1.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.3 | 6.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 7.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 31.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 3.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.3 | 0.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 1.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 1.1 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 1.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.3 | 1.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 5.6 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 14.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 1.1 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.3 | 3.5 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 7.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 1.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 5.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 1.6 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.3 | 1.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.3 | 1.0 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.3 | 2.5 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 10.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 5.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 1.9 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.2 | 4.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 4.0 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 0.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 7.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 4.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 2.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 3.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 1.3 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.2 | 1.3 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.2 | 0.7 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 1.3 | GO:0045174 | glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.2 | 1.3 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.2 | 2.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 1.5 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 1.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.2 | 1.0 | GO:0047756 | chondroitin sulfotransferase activity(GO:0034481) chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 1.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.6 | GO:1902121 | calcitriol receptor activity(GO:0008434) lithocholic acid receptor activity(GO:0038186) calcitriol binding(GO:1902098) lithocholic acid binding(GO:1902121) |
0.2 | 1.0 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.2 | 2.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 1.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 0.7 | GO:0043273 | CTPase activity(GO:0043273) |
0.2 | 3.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 1.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.5 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 3.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 1.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 0.7 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.2 | 1.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 1.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.5 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.2 | 4.6 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 0.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 0.6 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 1.3 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 9.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 0.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 2.0 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 2.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 1.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 1.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 1.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.4 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
0.1 | 1.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 14.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 3.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.8 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 1.8 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 2.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 2.6 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.8 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 7.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 4.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 5.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.6 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.1 | 4.6 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 0.7 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.5 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.1 | 0.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.6 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 1.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 5.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.2 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 1.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.3 | GO:0097689 | iron channel activity(GO:0097689) |
0.1 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 2.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 2.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.5 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.1 | 1.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 1.7 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 4.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 2.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 3.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.8 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 0.3 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 0.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 1.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 1.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 2.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 1.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.5 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.1 | 8.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 2.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 1.2 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.5 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 1.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.3 | GO:0051538 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 3.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 1.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 2.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 1.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.5 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.4 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 1.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 2.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 2.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 3.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 5.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 1.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 2.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.8 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 1.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 35.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 10.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.8 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 7.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 5.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 1.2 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.5 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.2 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.1 | 1.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 8.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.5 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 3.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 1.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 2.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 2.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.4 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.0 | 0.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.4 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 1.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 3.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.4 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 2.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.2 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.0 | 3.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.2 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 1.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.2 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.3 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.0 | 2.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 3.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.2 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.0 | 6.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 1.1 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.2 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.0 | 0.1 | GO:0044714 | GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
0.0 | 0.3 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 1.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.3 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
0.0 | 0.9 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.4 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.0 | 1.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 2.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 5.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 1.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 2.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.0 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.4 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 2.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 1.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.1 | GO:0033746 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
0.0 | 0.9 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 1.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 2.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 1.8 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 2.6 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.5 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 2.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 31.4 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 1.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 1.9 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.0 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 5.8 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 5.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.9 | 41.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 30.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 10.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.5 | 60.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.5 | 15.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 28.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 14.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 13.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 21.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 20.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 14.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 22.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 12.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 29.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 10.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 3.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 9.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 7.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 7.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 3.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 5.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 2.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 6.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 25.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 12.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 4.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 5.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 5.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 6.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.2 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 6.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 10.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 4.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 3.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 3.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 3.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 1.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 1.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 2.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 4.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 1.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.6 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 1.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 31.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.8 | 34.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.8 | 29.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.8 | 20.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.8 | 12.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.7 | 19.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.7 | 16.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.6 | 12.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 20.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.6 | 11.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.5 | 3.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.5 | 38.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.5 | 6.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 47.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 18.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 2.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 10.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.4 | 8.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 11.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 17.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 16.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 6.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 20.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 1.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 7.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 3.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 8.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 6.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 7.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 1.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 11.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 9.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 1.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 2.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 3.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 5.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 10.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 2.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 4.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 2.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 5.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 4.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 4.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 3.2 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 1.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 3.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 2.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 2.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 14.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 3.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 7.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 3.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 4.5 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 2.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 2.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 2.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 5.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 14.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 2.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 1.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 2.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 1.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 6.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 1.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 2.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 1.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 2.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 4.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 3.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 1.1 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.3 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.0 | 1.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 1.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.4 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 0.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 2.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 1.2 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.3 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |